Epoch 30 - Monetary Policy Shell Games to Lead a Biotech Recovery

An Alternative Scenario to Drive Risk-On in 2H22

Hello Avatar!  Welcome to another week of biotech analysis. Today’s commentary is more forward looking in nature - what can we expect in 2H22?  How real is this rally that we are in the midst of?  Over the past few weeks we have acknowledged the impressive bounce, but also noted we remain extremely concerned about the influence of the troubling macroeco…